[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

DelveInsight: Market Research Reports

DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:

  • Company’s profile and licensing data;
  • New technology studies;
  • Biologic benchmarking;
  • Treatment modality analysis;
  • Competitive landscape;
  • Product assessment; etc.


This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.

DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.

Publications found: 6,889
Sort by:

Vitiligo - Epidemiology Forecast to 2032

US$ 3,950.00

... epidemiology historical and forecasted data of Vitiligo prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease ... global Vitiligo market. Identifying prevalent patient populations as well as risk factors in the global Vitiligo market ...

January 2022 60 pages

Vitiligo - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

... in Vitiligo Vitiligo Pipeline Analysis Vitiligo Market Size and Trends Vitiligo Market Opportunities Impact of upcoming Therapies in Vitiligo Vitiligo Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Vitiligo Report ...

January 2022 200 pages

Vivacor - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Vivacor API intelligence over Vivacor and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Vivanza - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Vivanza API intelligence over Vivanza and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Volibris - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Volibris API intelligence over Volibris and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Votrient - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Votrient API intelligence over Votrient and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Votubia - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Votubia API intelligence over Votubia and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Vyvanse - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Vyvanse API intelligence over Vyvanse and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Xanax - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Xanax API intelligence over Xanax and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Xarelto - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Xarelto API intelligence over Xarelto and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Xelevia - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Xelevia API intelligence over Xelevia and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Xeloda - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Xeloda API intelligence over Xeloda and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Xenazine - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Xenazine API intelligence over Xenazine and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Xeristar - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Xeristar API intelligence over Xeristar and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Xeroquel LP - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Xeroquel LP API intelligence over Xeroquel LP and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Xopenex - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Xopenex API intelligence over Xopenex and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Xtandi - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Xtandi API intelligence over Xtandi and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Xyrem - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Xyrem API intelligence over Xyrem and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Xyzall - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Xyzall API intelligence over Xyzall and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Zactos - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Zactos API intelligence over Zactos and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Zaldiar - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Zaldiar API intelligence over Zaldiar and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Zeclar - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Zeclar API intelligence over Zeclar and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Zeffix - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Zeffix API intelligence over Zeffix and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Zelboraf - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Zelboraf API intelligence over Zelboraf and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Zelitrex - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Zelitrex API intelligence over Zelitrex and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Zemplar - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Zemplar API intelligence over Zemplar and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Zenhale - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Zenhale API intelligence over Zenhale and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Zienam - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Zienam API intelligence over Zienam and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Zient - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Zient API intelligence over Zient and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Zintrepid - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Zintrepid API intelligence over Zintrepid and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Zispin - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Zispin API intelligence over Zispin and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Zocor - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Zocor API intelligence over Zocor and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Zoloft - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Zoloft API intelligence over Zoloft and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Zoltec - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Zoltec API intelligence over Zoltec and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Zometa Concentrate - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Zometa Concentrate API intelligence over Zometa Concentrate and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Zortress - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Zortress API intelligence over Zortress and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Zosyn - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Zosyn API intelligence over Zosyn and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Zurcal - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Zurcal API intelligence over Zurcal and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Zyprexa - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Zyprexa API intelligence over Zyprexa and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Zytiga - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Zytiga API intelligence over Zytiga and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Aciphex - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Aciphex API intelligence over Aciphex and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Acromegaly - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Acromegaly Key assessments Patient Segmentation in Acromegaly Acromegaly Risk & Burden Factors driving growth in a specific Acromegaly patient population

January 2022 60 pages

Acthar Gel - API Insight, 2022

US$ 500.00

... patent expiry details with respect to Acthar Gel API intelligence over Acthar Gel and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...

January 2022 30 pages

Actinic Keratosis - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Actinic Keratosis Key assessments Patient Segmentation in Actinic Keratosis Actinic Keratosis Risk & Burden Factors driving growth in a specific Actinic Keratosis patient population

January 2022 60 pages

Acute Coronary Syndrome - Epidemiology Forecast to 2032

US$ 3,950.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Acute Coronary Syndrome Key assessments Patient Segmentation in Acute Coronary Syndrome Acute Coronary Syndrome Risk & Burden Factors driving growth in a specific Acute Coronary Syndrome patient population

January 2022 60 pages

Acute Coronary Syndrome - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

... Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Acute Coronary Syndrome Report Assessment Current Treatment Practices in Acute Coronary Syndrome Unmet Needs in Acute Coronary Syndrome Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...

January 2022 200 pages

Acute Renal Failure (ARF) (Acute Kidney Injury) - Epidemiology Forecast to 2032

US$ 3,950.00

... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Acute Renal Failure (ARF) (Acute Kidney Injury) Key assessments Patient Segmentation in Acute Renal Failure (ARF) (Acute Kidney Injury) Acute Renal Failure (ARF) (Acute Kidney Injury) Risk & Burden Factors driving growth ...

January 2022 60 pages

Acute Renal Failure (ARF) (Acute Kidney Injury) - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

... forecasting data and estimated market size. KEY COVERAGE Understanding historical and forecasted epidemiological data for Acute Renal Failure (ARF) (Acute Kidney Injury) covering 7MM from 2015-2025. Segment level epidemiology and market split for Acute Renal Failure (ARF) (Acute Kidney Injury ...

January 2022 200 pages

Acute Respiratory Distress Syndrome (ARDS) - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

... Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Acute Respiratory Distress Syndrome (ARDS) Report Assessment Current Treatment Practices in Acute Respiratory Distress Syndrome (ARDS) Unmet Needs in Acute Respiratory Distress Syndrome (ARDS) Market ...

January 2022 200 pages

Acute Respiratory Distress Syndrome - Epidemiology Forecast to 2032

US$ 3,950.00

... strengths 10 Year Forecast 7MM Coverage Total Cases in Acute Respiratory Distress Syndrome Key assessments Patient Segmentation in Acute Respiratory Distress Syndrome Acute Respiratory Distress Syndrome Risk & Burden Factors driving growth in a specific Acute Respiratory Distress Syndrome patient population

January 2022 60 pages

Filters

Search

Categories

5,477
618
651
143

Publishers

6,889

Regions

6,889

Price

Date

Pages

Offers